Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Climent

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2012
Incidence and predictors of ovarian function recovery (OFR) in breast cancer (BC) patients with chemotherapy-induced amenorrhea (CIA) who switched from tamoxifen to exemestaneA Guerrero, J Gavilá, E Folkerd, et al.
Breast (Edinburgh, Scotland)|February 18, 2004
Prognostic value of HER-2/neu and p53 expression in node-positive breast cancer. HER-2/neu effect on adjuvant tamoxifen treatmentM A Climent, M A Seguí, G Peiró, et al.
Breast Cancer Research and Treatment|April 1, 1995
A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancerM C Alonso, J M Tabernero, B Ojeda, et al.
Archivos Espanoles De Urologia|January 1, 1992
[Follow-up of patients with localized germinal testicular tumors: 6 years' experience at the "Santa Creu i Sant Pau" Hospital]M A Climent Duran, J R Germa Lluch, M A Seguí Palmer, et al.
British Journal of Urology|April 1, 1993
Treatment of stage I testicular tumoursJ R Germa Lluch, M A Climent, H Villavicencio, et al.
Medicina Clinica|October 19, 1991
[The modification of the toxicity produced by chemotherapy in testicular cancer by adapting its intensity to prognostic groups]R Blanco Guerrero, J R Germà Lluch, M A Climent Durán, et al.
European Urology|January 1, 1992
Intensive chemotherapy in poor-prognosis nonseminomatous germ cell tumors of the testisJ R Germá Lluch, M A Seguí Palmer, M A Climent Durán, et al.
Neurologia (Barcelona, Spain)|December 18, 2010
Long term prognosis of juvenile absence epilepsyM Aiguabella Macau, M Falip Centellas, M Veciana de Las Heras, et al.
In Vivo (Athens, Greece)|November 1, 1993
Oncogenic proteins and prognostic correlations in breast cancerR Molina, X Filelia, M A Segui, et al.
Medicina Clinica|November 2, 1991
[Lymphomas originating in the otorhinolaryngeal region: 10 years' experience]M A Climent, C Pallarés Curto, R Blanco Guerrero, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2012
Incidence and predictors of ovarian function recovery (OFR) in breast cancer (BC) patients with chemotherapy-induced amenorrhea (CIA) who switched from tamoxifen to exemestaneA Guerrero, J Gavilá, E Folkerd, et al.
Breast (Edinburgh, Scotland)|February 18, 2004
Prognostic value of HER-2/neu and p53 expression in node-positive breast cancer. HER-2/neu effect on adjuvant tamoxifen treatmentM A Climent, M A Seguí, G Peiró, et al.
Breast Cancer Research and Treatment|April 1, 1995
A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancerM C Alonso, J M Tabernero, B Ojeda, et al.
Archivos Espanoles De Urologia|January 1, 1992
[Follow-up of patients with localized germinal testicular tumors: 6 years' experience at the "Santa Creu i Sant Pau" Hospital]M A Climent Duran, J R Germa Lluch, M A Seguí Palmer, et al.
British Journal of Urology|April 1, 1993
Treatment of stage I testicular tumoursJ R Germa Lluch, M A Climent, H Villavicencio, et al.
Medicina Clinica|October 19, 1991
[The modification of the toxicity produced by chemotherapy in testicular cancer by adapting its intensity to prognostic groups]R Blanco Guerrero, J R Germà Lluch, M A Climent Durán, et al.
European Urology|January 1, 1992
Intensive chemotherapy in poor-prognosis nonseminomatous germ cell tumors of the testisJ R Germá Lluch, M A Seguí Palmer, M A Climent Durán, et al.
Neurologia (Barcelona, Spain)|December 18, 2010
Long term prognosis of juvenile absence epilepsyM Aiguabella Macau, M Falip Centellas, M Veciana de Las Heras, et al.
In Vivo (Athens, Greece)|November 1, 1993
Oncogenic proteins and prognostic correlations in breast cancerR Molina, X Filelia, M A Segui, et al.
Medicina Clinica|November 2, 1991
[Lymphomas originating in the otorhinolaryngeal region: 10 years' experience]M A Climent, C Pallarés Curto, R Blanco Guerrero, et al.
Pageof 5